TACE treatment in hepatocellular carcinoma: What should we do now?

被引：21
作者：
Farinati, Fabio [1 ]
Giacomin, Anna [1 ]
Vanin, Veronica [1 ]
Giannini, Edoardo [2 ]
Trevisani, Franco [3 ]
机构：
[1] Univ Padua, Dept Surg & Gastroenterol Sci, Gastroenterol Sect, Padua, Italy
[2] Univ Genoa, Dept Internal Med, Gastroenterol Sect, I-16126 Genoa, Italy
[3] Alma Mater Studiorum Univ Bologna, Dept Clin Med, Bologna, Italy
来源：
JOURNAL OF HEPATOLOGY | 2012年 / 57卷 / 01期
关键词：
TRANSARTERIAL LIPIODOL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;
D O I：
10.1016/j.jhep.2011.12.022
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：221 / 222
页数：2
相关论文
共 10 条
  • [1] Transarterial chemoembolization for unresectable hepatocellular carcinoma:: Meta-analysis of randomized controlled trials
    Cammà, C
    Schepis, F
    Orlando, A
    Albanese, M
    Shahied, L
    Trevisani, F
    Andreone, P
    Craxì, A
    Cottone, M
    [J]. RADIOLOGY, 2002, 224 (01) : 47 - 54
  • [2] Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (federation francophone de cancerologie digestive 9402)
    Doffoel, M.
    Bonnetain, F.
    Bouche, O.
    Vetter, D.
    Abergel, A.
    Fratte, S.
    Grange, J. D.
    Stremsdoerfer, N.
    Blanchi, A.
    Bronowicki, J. P.
    Caroli-Bosc, F. X.
    Causse, X.
    Masskouri, F.
    Rougier, P.
    Bedenne, L.
    [J]. EUROPEAN JOURNAL OF CANCER, 2008, 44 (04) : 528 - 538
  • [3] Eccles Martin, 2002, J Health Serv Res Policy, V7, P98, DOI 10.1258/1355819021927746
  • [4] Chemoembolization for intermediate HCC: Is there proof of survival benefit?
    Forner, Alejandro
    Llovet, Josep M.
    Bruix, Jordi
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 (04) : 984 - 986
  • [5] Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
    Llovet, JM
    Bruix, J
    [J]. HEPATOLOGY, 2003, 37 (02) : 429 - 442
  • [6] Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
    Llovet, JM
    Real, MI
    Montaña, X
    Planas, R
    Coll, S
    Aponte, J
    Ayuso, C
    Sala, M
    Muchart, J
    Solà, R
    Rodés, J
    Bruix, J
    [J]. LANCET, 2002, 359 (9319) : 1734 - 1739
  • [7] Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
    Lo, CM
    Ngan, H
    Tso, WK
    Liu, CL
    Lam, CM
    Poon, RTP
    Fan, ST
    Wong, J
    [J]. HEPATOLOGY, 2002, 35 (05) : 1164 - 1171
  • [8] Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
    Oliveri, Roberto S.
    Wetterslev, Jorn
    Gluud, Christian
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (03):
  • [9] A RANDOMIZED TRIAL OF HEPATIC ARTERIAL CHEMOEMBOLIZATION IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR-CARCINOMA
    PELLETIER, G
    ROCHE, A
    INK, O
    ANCIAUX, ML
    DERHY, S
    ROUGIER, P
    LENOIR, C
    ATTALI, P
    ETIENNE, JP
    [J]. JOURNAL OF HEPATOLOGY, 1990, 11 (02) : 181 - 184
  • [10] Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization:: a multicenter randomized trial
    Pelletier, G
    Ducreux, M
    Gay, F
    Luboinski, M
    Hagège, H
    Dao, T
    Van Steenbergen, W
    Buffet, C
    Rougier, P
    Adler, M
    Pignon, JP
    Roche, A
    [J]. JOURNAL OF HEPATOLOGY, 1998, 29 (01) : 129 - 134
1